Development And Characterisation ofrLS Polymerase Zeta Subunit MAD2B/Rev7 Targeted Inhibitors As Potential Anticancer Therapeutic Agents Using In-Vitro And Ln-Vivo Approach
Development And Characterisation ofrLS Polymerase Zeta Subunit MAD2B/Rev7 Targeted Inhibitors As Potential Anticancer Therapeutic Agents Using In-Vitro And Ln-Vivo Approach